About: Eva Gönczöl

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Eva Gönczöl Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	Hongaars arts (nl) (1936) magyar orvos, mikrobiológus (hu)
rdfs:label	Eva Gonczol (sq) Eva Gönczöl (en) Eva Gönczöl (nl) Eva Gönczöl (sl) Gönczöl Éva (hu)
skos:prefLabel	Eva Gonczol (sq) Eva Gönczöl (en) Eva Gönczöl (nl) Eva Gönczöl (sl) Gönczöl Éva (hu)
name	Eva Gonczol (sq) Eva Gönczöl (en) Eva Gönczöl (nl) Eva Gönczöl (sl) Gönczöl Éva (hu)
PIM authority ID	wds:Q86761237-f61d8b97-4e6c-c840-deb7-5a5e5de0e7ac
PIM authority ID	PIM37002
given name	wds:Q86761237-333e0633-42a7-94a6-a525-57236c1fd1bb
given name	Éva
instance of	wds:Q86761237-22E5C874-FCEB-433D-B897-C2806023D4AE
instance of	Homo sapiens
skos:altLabel	E Gonczol (en) E Gönczöl (en) E. Gonczol (en) E. Gönczöl (en) Eva Gonczol (en) Eva Gönczöl (tr) Gonczol (en) Gonczol E (en) Gonczol E. (en) Gönczöl (en) Gönczöl E (en) Gönczöl E. (en)
occupation	wds:Q86761237-e3548f48-4046-66e6-ea45-804e235e6c82 wds:Q86761237-ec74ef64-4609-959e-6bd6-63d5420b9241
employer	wds:Q86761237-f7e91db3-4774-bb92-224a-cbcef205b260
place of birth	wds:Q86761237-b589c90f-46d4-e7cf-70a2-cc1d93269522
sex or gender	wds:Q86761237-b9f7b93b-4518-e585-af7e-b833e3378e49
country of citizenship	wds:Q86761237-0ecc117f-4a2c-619f-8a15-4930a618e3f9
date of birth	wds:Q86761237-53b55906-4e05-f357-db4e-4adf3cb28070
occupation	microbiologist physician
employer	National Centre for Epidemiology
place of birth	Veszprém
sex or gender	female organism
country of citizenship	Hungary
date of birth	1936-09-28 00:00:00Z (xsd:dateTime)
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q86761237
is author of	Chlamydia pneumoniae in atherosclerotic middle cerebral artery Human cytomegalovirus latency is associated with the state of differentiation of the host cells: an in vitro model in teratocarcinoma cells Cytomegalovirus infection of human teratocarcinoma cells in culture Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge The safety and use of canarypox vectored vaccines Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidate A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. Development of a cytomegalovirus vaccine: lessons from recent clinical trials Genotyping of Chlamydia trachomatis from the endocervical specimens of high-risk women in Hungary Optimization of DNA immunization against human cytomegalovirus Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection Delayed type hypersensitivity to human cytomegalovirus Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs Cytomegalovirus Replicates in Differentiated But Not in Undifferentiated Human Embryonal Carcinoma Cells Human cytomegalovirus induces stage-specific embryonic antigen 1 in differentiating human teratocarcinoma cells and fibroblasts Fast vaccine design and development based on correlates of protection (COPs). Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Humoral immune response to cytomegalovirus Towne vaccine strain and to Toledo low-passage strain Infection of U937 Monocytic Cells withChlamydia pneumoniaeInduces Extensive Changes in Host Cell Gene Expression Expression of the human cytomegalovirus genome in mouse cells and in human-mouse heterokaryons Transformation of hamster embryonic fibroblast cells by UV-irradiated human cytomegalovirus Human colorectal cancer (CRC) antigen CO17-1A/GA733 encoded by adenovirus inhibits growth of established CRC cells in mice. Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1). Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. DNA-binding proteins that interact with the 19-base pair (CRE-like) element from the HCMV major immediate early promoter in differentiating human embryonal carcinoma cells The interactions between human dendritic cells and microbes; possible clinical applications of dendritic cells Expression of bacterial genes and induction of INF-gamma in human myeloid dendritic cells during persistent infection with Chlamydophila pneumoniae Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice. Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlr(tm1Her) Apob(tm2Sgy) J mice. Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies Immune responses to isolated human cytomegalovirus envelope proteins Inflammatory- and immune responses in relation to bacterial replication in mice following re-infections with Chlamydophila pneumoniae. Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung. Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge Virus-specific changes in mouse cells inoculated with a strain of human cytomegalovirus Activation of herpes specific antigens and infectious virus in a hamster cell line transformed by HSV-2. "Early, non-virion" antigens in herpes simplex virus infected tissue culture cells. II. Intracellular localization of "early" antigen with indirect immunofluorescence technique Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software